number of access : ?
number of downloads : ?
ID 115863
Author
Bando, Hiroshi Tokushima University|Japan Low Carbohydrate Diet Promotion Association KAKEN Search Researchers
Keywords
American Diabetes Association (ADA)
Dual Action of Liraglutide and Insulin Degludec (DUAL) studies
Xultophy
Multiple Daily Injection (MDI)
Once Daily Injection
Content Type
Journal Article
Description
American Diabetes Association (ADA) has announced the new version of the standards of Medical Care in Diabetes-2021. The guideline of the diabetic patients with Older Adults seems to be used for a wide range of clinical practice. Among them, several impressive comments were found, where “Once-daily basal insulin injection therapy is associated with minimal side effects and maybe a reasonable option in many elder patients”. Recent topic includes Dual Action of Liraglutide and insulin degludec (DUAL) studies, and Xultophy has shown beneficial efficacy. Consequently, the trend would be developed from multiple daily injection (MDI) method to once daily injection.
Journal Title
Diabetes Research : Open Access
Publisher
Asploro
Volume
3
Issue
1
Start Page
11
End Page
15
Published Date
2021-02-17
Rights
This is an open-access article distributed under the Creative Commons Attribution License(https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
DOI (Published Version)
URL ( Publisher's Version )
FullText File
language
eng
TextVersion
Publisher
departments
Medical Sciences